Clinical Trial Update: Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating the efficacy and safety of inhaled treprostinil for progressive pulmonary fibrosis, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Lung Disease
• Progressive Pulmonary Fibrosis

Drugs mentioned

• Tyvaso (treprostinil inhalation) (Treprostinil)

Snippet

Sponsor: United Therapeutics | Conditions: Progressive Pulmonary Fibrosis, Interstitial Lung Disease | Phase 3 | Status: RECRUITING